Skip to main content
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in:

Open Access 01-05-2025 | Efgartigimod | Correction

Correction: A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients

Authors: Chiara Pane, Vincenzo Di Stefano, Nunzia Cuomo, Alessio Sarnataro, Claudia Vinciguerra, Liliana Bevilacqua, Filippo Brighina, Nicasio Rini, Giorgia Puorro, Angela Marsili, Matteo Garibaldi, Laura Fionda, Francesco Saccà

Published in: Journal of Neurology | Issue 5/2025

Login to get access
Metadata
Title
Correction: A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
Authors
Chiara Pane
Vincenzo Di Stefano
Nunzia Cuomo
Alessio Sarnataro
Claudia Vinciguerra
Liliana Bevilacqua
Filippo Brighina
Nicasio Rini
Giorgia Puorro
Angela Marsili
Matteo Garibaldi
Laura Fionda
Francesco Saccà
Publication date
01-05-2025
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 5/2025
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-025-13061-9

Other articles of this Issue 5/2025

Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay–Sachs and Sandhoff diseases

Distinct patterns of cerebral and spinal pathology along the spectrum of ATXN2-related disorders

The natural history of body-first versus brain-first Parkinson’s disease subtypes

Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis

Added value of optic nerve lesions for multiple sclerosis diagnostic criteria

Correction: Marriage is associated with decreased lesion volumes and less brain atrophy in people with multiple sclerosis

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest
Image Credits